Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Hwi Pharma Services GmbH currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being reviewed by 1 distinct examiner in a distinct art unit. This represents a very focused level of activity at the patent office. The concentration in a single art unit suggests that the company's pharmaceutical innovations are being reviewed by a specialized group with consistent examination standards.
Examiner YU, HONG is the busiest examiner, managing the pending office action. Because this is the company's only active case, the official's specific review will dictate the immediate outcome of the prosecution. Practitioners should focus on the requirements of this examiner within the art unit. This centralized environment allows for a direct dialogue with the patent office, as there are no other active examiners or art units to coordinate with at this time, ensuring a streamlined prosecution process for the 1 pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YU, HONG | 1 | 31.1% | +5.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| Art Unit | Apps |
|---|---|
| 1614 | 1 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHwi Pharma Services GmbH has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Hong Yu has the most, with 1 of Hwi Pharma Services GmbH's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
